180 Life Sciences Stock Performance
| ATNF Stock | USD 1.88 0.05 2.73% |
180 Life holds a performance score of 10 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of 1.41, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, 180 Life will likely underperform. Use 180 Life Sciences value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to analyze future returns on 180 Life Sciences.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in 180 Life Sciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, 180 Life reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:19 | Last Split Date 2024-02-28 |
1 | Acquisition by Jordan Blair of 1318000 shares of 180 Life subject to Rule 16b-3 | 04/28/2025 |
2 | 180 Life Sciences Corp. Announces Share Repurchase ATNF Stock News | 04/30/2025 |
3 | 180 Life Sciences Secures Patent Approval for POCD Treatment Method ATNF Stock News | 05/01/2025 |
4 | 180 Life Sciences files to sell 753K shares of common stock for holders - MSN | 05/12/2025 |
5 | Insider Trading | 06/03/2025 |
6 | Acquisition by Deluca Teresa of 2500 shares of 180 Life at 3.98 subject to Rule 16b-3 | 06/12/2025 |
7 | Acquisition by Smith Ryan Lewis of 109541 shares of 180 Life subject to Rule 16b-3 | 06/17/2025 |
8 | 180 Life Sciences Adopts 2025 Option Incentive Plan - TipRanks | 06/18/2025 |
9 | 180 Life Sciences Schedules 2025 Annual Shareholder Meeting - TipRanks | 06/25/2025 |
10 | Disposition of 160000 shares by Jordan Blair of 180 Life subject to Rule 16b-3 | 07/07/2025 |
11 | 12 Health Care Stocks Moving In Fridays Pre-Market Session | 07/18/2025 |
| Begin Period Cash Flow | 2 M |
180 Life Relative Risk vs. Return Landscape
If you would invest 89.00 in 180 Life Sciences on April 20, 2025 and sell it today you would earn a total of 99.00 from holding 180 Life Sciences or generate 111.24% return on investment over 90 days. 180 Life Sciences is currently generating 2.0235% in daily expected returns and assumes 15.7775% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than 180, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
180 Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for 180 Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as 180 Life Sciences, and traders can use it to determine the average amount a 180 Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1282
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ATNF | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 15.78 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.02 actual daily | 40 60% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average 180 Life is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 180 Life by adding it to a well-diversified portfolio.
180 Life Fundamentals Growth
180 Stock prices reflect investors' perceptions of the future prospects and financial health of 180 Life, and 180 Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 180 Stock performance.
| Return On Equity | -2.21 | ||||
| Return On Asset | -0.55 | ||||
| Current Valuation | 1.29 M | ||||
| Shares Outstanding | 6.04 M | ||||
| Price To Earning | 0.63 X | ||||
| Price To Book | 0.71 X | ||||
| EBITDA | (6.32 M) | ||||
| Net Income | (6.17 M) | ||||
| Cash And Equivalents | 1.63 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 154.5 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 0.67 X | ||||
| Book Value Per Share | 1.49 X | ||||
| Cash Flow From Operations | (1.48 M) | ||||
| Earnings Per Share | (14.48) X | ||||
| Market Capitalization | 11.35 M | ||||
| Total Asset | 12.76 M | ||||
| Retained Earnings | (141.52 M) | ||||
| Working Capital | 1.64 M | ||||
About 180 Life Performance
By analyzing 180 Life's fundamental ratios, stakeholders can gain valuable insights into 180 Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if 180 Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if 180 Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | -2.4 K | -2.3 K | |
| Return On Tangible Assets | (1.20) | (1.26) | |
| Return On Capital Employed | (0.68) | (0.72) | |
| Return On Assets | (0.48) | (0.51) | |
| Return On Equity | (0.67) | (0.63) |
Things to note about 180 Life Sciences performance evaluation
Checking the ongoing alerts about 180 Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for 180 Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| 180 Life Sciences is way too risky over 90 days horizon | |
| 180 Life Sciences may become a speculative penny stock | |
| 180 Life Sciences appears to be risky and price may revert if volatility continues | |
| 180 Life Sciences currently holds 154.5 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. 180 Life Sciences has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about 180 Life's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (6.17 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| 180 Life Sciences currently holds about 1.63 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Roughly 44.0% of 180 Life shares are held by company insiders | |
| Latest headline from benzinga.com: 12 Health Care Stocks Moving In Fridays Pre-Market Session |
- Analyzing 180 Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether 180 Life's stock is overvalued or undervalued compared to its peers.
- Examining 180 Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating 180 Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of 180 Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of 180 Life's stock. These opinions can provide insight into 180 Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for 180 Stock analysis
When running 180 Life's price analysis, check to measure 180 Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 180 Life is operating at the current time. Most of 180 Life's value examination focuses on studying past and present price action to predict the probability of 180 Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 180 Life's price. Additionally, you may evaluate how the addition of 180 Life to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |